期刊文献+

基于FFPE组织切片的膀胱癌N-连接糖链原位酶解及分析 被引量:1

In Situ Enzymatic Hydrolysis and Analysis of Bladder Cancer N-glycans Based on FFPE Tissue Sections
下载PDF
导出
摘要 目的研究膀胱癌FFPE组织切片的N-连接糖链,发现膀胱癌FFPE肿瘤组织的异常N-连接糖链修饰情况。方法发展基于FFPE组织切片原位提取N-连接糖链的实验流程。通过PNGase F酶切FFPE组织解释放N-连接糖链。对N-连接糖链自由端进行全甲基化修饰。通过MALDI-TOF/TOF-MS检测N-连接糖链的相对含量。进行数据库匹配,确定N-连接糖链的可能糖型。ROC分析用于预测显著差异N-连接糖链作为预测膀胱癌生物标志物的准确度。结果MALDI-TOF/TOF-MS检测泛甲基化修饰N-连接糖链的数据显示,在16例膀胱癌患者的肿瘤和癌旁组织的3次重复实验中,肿瘤组织中蛋白质高甘露糖型N2H6、N2H7、N2H8、N2H9和复杂型N5H6F1糖链修饰水平显著上升,同时高甘露糖型N2H5、杂合型N3H5以及复杂型N3H4、N4H4、N5H6F1S2糖链修饰水平显著下降。ROC分析显示,双天线型N-连接糖链N3H4(AUC=0.90)和N4H4(AUC=0.91)在单独或者共同区分膀胱癌患者肿瘤组织和癌旁组织中都具有很好的可靠性,可能成为膀胱癌的潜在生物标志物。结论膀胱癌FFPE肿瘤组织中存在蛋白质异常N-糖基化修饰,N-连接糖链N3H4和N4H4或可成为膀胱癌的潜在生物标志物。 Objective To investigated the N-linked glycans in bladder cancer FFPE tissue sections,and explored abnormal N-linked glycans modification in bladder cancer FFPE tumor tissues sections.Methods An experimental procedure for in situ extraction of N-linked glycans based on FFPE tissue sections was developed.FFPE tissue sections were digested by PNGase F and liberated N-linked glycans.Permethylation was performed to modify the free end of the N-linked glycans.The relative intensity of N-linked glycans was detected by MALDI-TOF/TOF-MS.Database matching was performed to determine possible glycoforms of N-linked glycans.The accuracy of significantly different N-linked glycans as a predictive bladder cancer biomarker were predicted by ROC analysis.Results The data of MALDI-TOF/TOF-MS detection of premethylation-modified N-linked glycans showed that,in tumor and peritumoral FFPE tissue sections of 16 patients with bladder cancer,the relative intensity of N-linked glycans N2H6,N2H7,N2H8,N2H9(high mannose)and N5H6F1(complex)were increased significantly in the tumor tissues of bladder cancer.At the same time,N2H5(high mannose),N3H5(hybrid)and type N3H4,N4H4,N5H6F1S2(complex)N-linked glycans were significantly decreased.ROC analysis showed that the biantennary N-linked glycan N3H4(AUC=0.90)and N4H4(AUC=0.91)were reliable in distinguishing tumor and peritumoral tissue of bladder cancer patients separately or combined together,and these N-linked glycans may become a potential biomarker for bladder cancer.Conclusion Abnormal N-glycosylation of proteins in bladder cancer FFPE tumor tissue,N-linked glycans N3H4 and N4H4 may be potential biomarkers of bladder cancer.
作者 程颖 孙承文 秦艳 时帅 李岳阳 樊启高 杨刚龙 高晓冬 CHENG Ying;SUN Cheng-Wen;QIN Yan;SHI Shuai;LI Yue-Yang;FAN Qi-Gao;YANG Gang-Long;GAO Xiao-Dong(Key Laboratory of Carbohydrate Chemistry&Biotechnology,Ministry of Education,School of Biotechnology,Jiangnan University,Wuxi 214122,China;Department of Urology,Jiangnan University Affiliated Hospitals,Wuxi 214028,China;Department of Pathology,Jiangnan University Affiliated Hospitals,Wuxi 214028,China;School of Internet of Things Engineering,Jiangnan University,Wuxi 214122,China;School of Artificial Intelligence and Computer Science,Jiangnan University,Wuxi 214122,China)
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2022年第10期2001-2014,共14页 Progress In Biochemistry and Biophysics
基金 国家自然科学基金(21778023)资助项目。
关键词 N-连接糖链 膀胱癌 FFPE切片 生物标志物 N-linked glycan bladder cancer FFPE section biomarker
  • 相关文献

参考文献1

二级参考文献19

  • 1Goodison S, Rosser C J, Urquidi V. Bladder cancer detection and monitoring: assessment of urine- and blood-based marker tests. Molecular Diagnosis & Therapy, 2013, 17(02): 71-84.
  • 2Cheng L, Davison D D, Adams J, et ol. Biomarkers in bladder cancer: translational and clinical implications. Critical Reviews in Oncology/Hematology, 2014, 89(01): 73-111.
  • 3Zielinska D F, Gnad F, Wiffniewski J R, et 01. Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell, 2010, 141(05): 897-907.
  • 4Hart G W, Copeland R J. Glycomics hits the big time. Cell, 2010, 143(05): 672-676.
  • 5Lan K S, Partridge E A, Grigorian A, et 01. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell, 2007, 129(01 ): 123-134.
  • 6Zeng X, Hood B L, Sun M, et al. Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry. Journal of Proteome Research, 2010, 9 (12): 6440-6449.
  • 7Zeng Z, Hincapie M, Haab B B, et 01. The development of an integrated platform to identify breast cancer glycoproteome changes in human serum. Journal of Chromatography A, 2010, 1217(19): 3307-3315.
  • 8Tian Y, Bova G S, Zhang H. Quantitative glycoproteomic analysis of optimal cutting temperature-embedded frozen tissues identifying glycoproteins associated with aggressive prostate cancer. Analytical Chemistry, 2011, 83( 18): 7013-7019.
  • 9Yang G, Cui T, Wang Y, et al. Selective isolation and analysis of glycoprotein fractions and their glycomes from hepatocellular carcinoma sera. Proteomics, 2013, 13(09): 1481-1498.
  • 10Kreunin P, Zhao J, Rosser C, et ol. Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling. Journal of Proteome Research, 2007, 6(07): 2631-2639.

共引文献2

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部